Nabilone for the Treatment of Paraneoplastic Night Sweats: A Report of Four Cases
Publication: Journal of Palliative Medicine
Volume 11, Issue Number 6
ABSTRACT
Night sweats are one of many symptoms experienced by patients with advanced cancer. The prevalence of night sweats ranges from 10%–48% in cancer patients. Persistent night sweats tend to decrease quality of life through interference with sleep. A recent study has demonstrated that night sweats occur as part of a symptom pattern, and are associated with the anorexia–cachexia symptom cluster. In addition, night sweats represent one of the symptoms that displays a tendency not to improve as patients with advanced cancer approach end of life. This paper serves to report on the successful management of four patients suffering from persistent paraneoplastic night sweats using the synthetic orally administered cannabinoid nabilone. The four patients had been referred to a regional consultative palliative medicine program and identified night sweats as one of their most significant symptomatic concerns reported on their Edmonton Symptom Assessment System (ESAS) questionnaires.
Get full access to this article
View all available purchase options and get full access to this article.
Information & Authors
Information
Published In
Journal of Palliative Medicine
Volume 11 • Issue Number 6 • July/August 2008
Pages: 929 - 934
PubMed: 18715188
Copyright
© 2008 Mary Ann Liebert, Inc.
History
Published online: 21 August 2008
Published in print: July/August 2008
Topics
Authors
Metrics & Citations
Metrics
Citations
Export Citation
Export citation
Select the format you want to export the citations of this publication.
View Options
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.⚠ Society Access
If you are a member of a society that has access to this content please log in via your society website and then return to this publication.